pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
COMPANY OVERVIEW
Agilis Biotherapeutics is advancing innovative DNA therapeutics designed to provide long-term efficacy for patients with debilitating, often fatal, rare genetic diseases that affect the central nervous system.
LOCATION
Cambridge, MA, USA
THERAPEUTIC AREAS
Rare Diseases
WEBSITE
https://www.agilisbio.com/
CAREER WEBSITE
None
SOCIAL MEDIA
INVESTORS
PRESS RELEASES
Aug 23, 2018
PTC Therapeutics Successfully Completes Acquisition of Agilis Biotherapeutics
May 16, 2018
Agilis Biotherapeutics Conducts a Scientific Symposium for Education and Awareness of AADC Deficiency at the 21st Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
May 14, 2018
Agilis Biotherapeutics Announces Data Presentations on AADC Deficiency at the American Society of Gene and Cell Therapy 2018 Annual Meeting
May 2, 2018
Agilis Biotherapeutics Presents on Gene Therapy Pricing Strategies at the 2nd Annual Gene Therapy for Rare Disorders Summit
Apr 24, 2018
Agilis Biotherapeutics Presents Platform Paper on AADC Deficiency Gene Therapy at American Academy of Neurology Annual Meeting
For More Press Releases